Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Larosa

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Critical Care Clinics|July 5, 2005
Tissue factor pathway inhibitor and antithrombin trial resultsSteven P LaRosa, Steven M Opal
Plos One|December 4, 2014
Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from blood by heparin-functional hemoperfusion mediaKeith McCrea, Robert Ward, Steven P LaRosa
Dermatologic Clinics|April 20, 2005
What's new in antibiotics?Ravindran A Padmanabhan, Steven P Larosa, Kenneth J Tomecki
Plos One|July 28, 2022
Removal of clinically relevant SARS-CoV-2 variants by an affinity resin containing Galanthus nivalis agglutininMelanie Gooldy, Christelle M Roux, Steven P LaRosa, et al.
Shock (Augusta, Ga.)|June 25, 2011
Influence of severity of illness on the effects of eritoran tetrasodium (E5564) and on other therapies for severe sepsisAndre C Kalil, Steven P LaRosa, Jagadish Gogate, et al.
Transplant Immunology|March 2, 2025
A lectin affinity plasmapheresis device removes extracellular vesicles and microRNAs from renal perfusates following controlled oxygenated rewarming of discarded donor kidneysRosalia de Necochea Campion, Miguel Pesqueira, Paul Vallejos, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 9, 2019
Time for Well-Powered Controlled Prospective Studies to Test a Causal Role for Herpes Viruses in Alzheimer's Disease Using Antiherpetic DrugsPascal J Goldschmidt-Clermont, Fred G Volinsky, Steven P LaRosa, et al.
Frontiers in Medicine|October 25, 2021
Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 InfectionDennis E Amundson, Usman S Shah, Rosalia de Necochea-Campion, et al.
Critical Care Medicine|August 8, 2009
Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsisMark Tidswell, William Tillis, Steven P Larosa, et al.
Critical Care (London, England)|March 17, 2009
A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumoniaPierre-François Laterre, Steven M Opal, Edward Abraham, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Critical Care Clinics|July 5, 2005
Tissue factor pathway inhibitor and antithrombin trial resultsSteven P LaRosa, Steven M Opal
Plos One|December 4, 2014
Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from blood by heparin-functional hemoperfusion mediaKeith McCrea, Robert Ward, Steven P LaRosa
Dermatologic Clinics|April 20, 2005
What's new in antibiotics?Ravindran A Padmanabhan, Steven P Larosa, Kenneth J Tomecki
Plos One|July 28, 2022
Removal of clinically relevant SARS-CoV-2 variants by an affinity resin containing Galanthus nivalis agglutininMelanie Gooldy, Christelle M Roux, Steven P LaRosa, et al.
Shock (Augusta, Ga.)|June 25, 2011
Influence of severity of illness on the effects of eritoran tetrasodium (E5564) and on other therapies for severe sepsisAndre C Kalil, Steven P LaRosa, Jagadish Gogate, et al.
Transplant Immunology|March 2, 2025
A lectin affinity plasmapheresis device removes extracellular vesicles and microRNAs from renal perfusates following controlled oxygenated rewarming of discarded donor kidneysRosalia de Necochea Campion, Miguel Pesqueira, Paul Vallejos, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 9, 2019
Time for Well-Powered Controlled Prospective Studies to Test a Causal Role for Herpes Viruses in Alzheimer's Disease Using Antiherpetic DrugsPascal J Goldschmidt-Clermont, Fred G Volinsky, Steven P LaRosa, et al.
Frontiers in Medicine|October 25, 2021
Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 InfectionDennis E Amundson, Usman S Shah, Rosalia de Necochea-Campion, et al.
Critical Care Medicine|August 8, 2009
Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsisMark Tidswell, William Tillis, Steven P Larosa, et al.
Critical Care (London, England)|March 17, 2009
A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumoniaPierre-François Laterre, Steven M Opal, Edward Abraham, et al.
Pageof 4